BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22168834)

  • 1. Advanced electrocardiographic parameters change with severity of mitral regurgitation in Cavalier King Charles Spaniels in sinus rhythm.
    Spiljak Pakkanen M; Domanjko Petrič A; Olsen LH; Stepančič A; Schlegel TT; Falk T; Rasmussen CE; Starc V
    J Vet Intern Med; 2012; 26(1):93-100. PubMed ID: 22168834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. R-R interval variations influence the degree of mitral regurgitation in dogs with myxomatous mitral valve disease.
    Reimann MJ; Møller JE; Häggström J; Markussen B; Holen AE; Falk T; Olsen LH
    Vet J; 2014 Mar; 199(3):348-54. PubMed ID: 24507881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.
    Reimann MJ; Møller JE; Häggström J; Martinussen T; Zatrazemi SSC; Svanholm L; Nielsen LBM; Pedersen HD; Olsen LH
    J Vet Intern Med; 2017 Jul; 31(4):1008-1016. PubMed ID: 28573754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow-mediated vasodilation measurements in Cavalier King Charles Spaniels with increasing severity of myxomatous mitral valve disease.
    Moesgaard SG; Klostergaard C; Zois NE; Teerlink T; Molin M; Falk T; Rasmussen CE; Luis Fuentes V; Jones ID; Olsen LH
    J Vet Intern Med; 2012; 26(1):61-8. PubMed ID: 22151409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
    Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
    J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of changes in hemostatic markers in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
    Tarnow I; Kristensen AT; Olsen LH; Pedersen HD
    Am J Vet Res; 2004 Dec; 65(12):1644-52. PubMed ID: 15631028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
    Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
    J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate variability in relation to severity of mitral regurgitation in Cavalier King Charles spaniels.
    Häggström J; Hamlin RL; Hansson K; Kvart C
    J Small Anim Pract; 1996 Feb; 37(2):69-75. PubMed ID: 8656596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentration of atrial natriuretic peptide in relation to severity of mitral regurgitation in Cavalier King Charles Spaniels.
    Häggström J; Hansson K; Karlberg BE; Kvart C; Olsson K
    Am J Vet Res; 1994 May; 55(5):698-703. PubMed ID: 8067620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective pilot study on the predictive significance of plasma miR-30b-5p through the study of echocardiographic modifications in Cavalier King Charles Spaniels affected by different stages of myxomatous mitral valve disease: The PRIME study.
    Ghilardi S; Lecchi C; Bagardi M; Romito G; Colombo FM; Polli M; Franco C; Brambilla PG
    PLoS One; 2022; 17(12):e0274724. PubMed ID: 36574372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volumetric quantification identifies some left atrial dilations undetected by left atrium:aorta ratio measurements: A prospective echocardiographic study in 155 Cavalier King Charles Spaniels with and without degenerative mitral valve disease.
    Chetboul V; Poissonnier C; Foulex P; Alvarado MP; Trehiou-Sechi É; Saponaro V; Passavin P; Desquilbet L
    PLoS One; 2024; 19(3):e0300827. PubMed ID: 38547236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic mitral valve prolapse in cavalier King Charles spaniels: epidemiology and prognostic significance for regurgitation.
    Pedersen HD; Lorentzen KA; Kristensen BO
    Vet Rec; 1999 Mar; 144(12):315-20. PubMed ID: 10212505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of physical examination, electrocardiography, radiography, and biomarkers to predict echocardiographic stage B2 myxomatous mitral valve disease in preclinical Cavalier King Charles Spaniels.
    Wesselowski S; Gordon SG; Fries R; Saunders AB; Sykes KT; Vitt J; Boutet B; Häggström J; Kadotani S; Stack J; Barnett BG
    J Vet Cardiol; 2023 Dec; 50():1-16. PubMed ID: 37913604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Echocardiographic Findings in an Aged Population of Cavalier King Charles Spaniels.
    Prieto Ramos J; Corda A; Swift S; Saderi L; De La Fuente Oliver G; Corcoran B; Summers KM; French AT
    Animals (Basel); 2021 Mar; 11(4):. PubMed ID: 33800666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent mitral regurgitation in Cavalier King Charles spaniels: Short-term progression and influence of stress tests.
    Reimann MJ; Møller JE; Häggström J; Åkerström LLB; Martinussen T; Olsen LH
    Vet J; 2020 Apr; 258():105457. PubMed ID: 32564867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of 2 loci associated with development of myxomatous mitral valve disease in Cavalier King Charles Spaniels.
    Madsen MB; Olsen LH; Häggström J; Höglund K; Ljungvall I; Falk T; Wess G; Stephenson H; Dukes-McEwan J; Chetboul V; Gouni V; Proschowsky HF; Cirera S; Karlskov-Mortensen P; Fredholm M
    J Hered; 2011; 102 Suppl 1():S62-7. PubMed ID: 21846748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of natriuretic peptides in dogs with mitral valve disease.
    Tarnow I; Olsen LH; Kvart C; Hoglund K; Moesgaard SG; Kamstrup TS; Pedersen HD; Häggström J
    Vet J; 2009 May; 180(2):195-201. PubMed ID: 18675567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of mitral valve regurgitation in dogs with degenerative mitral valve disease by use of the proximal isovelocity surface area method.
    Gouni V; Serres FJ; Pouchelon JL; Tissier R; Lefebvre HP; Nicolle AP; Sampedrano CC; Chetboul V
    J Am Vet Med Assoc; 2007 Aug; 231(3):399-406. PubMed ID: 17669041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of enalapril for prevention of congestive heart failure in dogs with myxomatous valve disease and asymptomatic mitral regurgitation.
    Kvart C; Häggström J; Pedersen HD; Hansson K; Eriksson A; Järvinen AK; Tidholm A; Bsenko K; Ahlgren E; Ilves M; Ablad B; Falk T; Bjerkfås E; Gundler S; Lord P; Wegeland G; Adolfsson E; Corfitzen J
    J Vet Intern Med; 2002; 16(1):80-8. PubMed ID: 11822810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rate of change of heart size before congestive heart failure in dogs with mitral regurgitation.
    Lord P; Hansson K; Kvart C; Häggström J
    J Small Anim Pract; 2010 Apr; 51(4):210-8. PubMed ID: 20406369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.